MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?

This publication has 27 references indexed in Scilit:

• Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reaction
  Arthritis & Rheumatism, 2002
• Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice
  Arthritis & Rheumatism, 2002
• Ongoing trials with matrix metalloproteinase inhibitors
  Expert Opinion on Investigational Drugs, 2000
• Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts
  Arthritis & Rheumatism, 2000
• Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate
  Matrix Biology, 1999
• Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis
  Arthritis & Rheumatism, 1999
• New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above
  Matrix Biology, 1998
• Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells
  Journal of Biological Chemistry, 1997
• Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo
  British Journal of Pharmacology, 1997
• Markedly Elevated Serum MMP-9 (Gelatinase B) Levels in Rheumatoid Arthritis: A Potentially Useful Laboratory Marker
  Clinical Immunology and Immunopathology, 1996